The US diabetes devices market is booming, projected to reach over $40 billion by 2033, driven by rising diabetes prevalence and advancements in CGM and insulin delivery systems. This in-depth analysis covers market size, growth trends, key players (Abbott, Medtronic, Dexcom), and regional insights. Explore the future of diabetes management technology.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.